David Sinclair’s $101M XPRIZE plans “age restoration” with human reprogramming drug tests
A longevity bet turns into human trials, with a one-year scorecard tied to immune, cognitive, and muscle recovery.
By Yousef Al-Zahrani·· 4 min
2 briefings · “reprogramming”
A longevity bet turns into human trials, with a one-year scorecard tied to immune, cognitive, and muscle recovery.
The Harvard biologist says he will test a swallowed “reprogramming” drug aimed at measurable immune, cognitive, and muscle gains.